TOKYO -- Olympus will expand its sales force and offer new, high-performance surgical tools to try cutting into the Chinese market for medical devices.
The Japanese optical equipment producer aims to more than double the Chinese hospitals using its endoscopes and other devices to 3,000 by 2019. It faces rising competition from local manufacturers whose primary advantage is low costs.
With people in China increasingly seeking early detection and treatment of digestive tract cancers, Olympus plans to enlarge its medical devices sales force there by 10% to 660 by next spring. The roughly 1,300 hospitals now using its devices are concentrated in major metropolitan areas, so the company wants to branch out into second- and third-tier cities.
Olympus will also provide training in minimally invasive surgical procedures, like those commonly used to remove abdominal cancer tissue in Japan, at its four Chinese training centers.
To improve after-sales service, the company plans to double its maintenance capacity in China to roughly 20,000 scopes a year by 2019.
Olympus will also sell a new type of proprietary surgical tool there that can cut and cauterize tissue with both high-frequency electric current and ultrasonic vibrations.
China's roughly $20 billion medical devices market ranked fourth in size worldwide last year and is poised to grow to $33 billion by 2017, becoming second only to the U.S., estimates by U.K.-based Espicom Business Intelligence show.
Olympus' medical business saw sales rise nearly 30% in the Asia-Pacific region in fiscal 2013, with China accounting for about half of the 69.7 billion yen ($677 million) total.
Other Japanese medical device manufacturers are also seeking growth in China.
Toshiba Medical Systems released an MRI scanner there in February. This was only a year or so after the product went on sale in Japan -- far sooner than the typical delay of about two years. The company shortened the wait by seeking approval for the scanner in parallel in both countries.
Terumo is equipping sales units in China to provide training in the use of catheters.
These Japanese suppliers see improving product performance and after-sales service as essential for competing against low-cost Chinese rivals.